Global Brachytherapy Market to Reach $2.3 Billion by 2030
The global market for Brachytherapy estimated at US$1.6 Billion in the year 2022, is projected to reach a revised size of US$2.3 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2022-2030. High Dose Rate, one of the segments analyzed in the report, is projected to record 4% CAGR and reach US$1.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Low Dose Rate segment is readjusted to a revised 5.9% CAGR for the next 8-year period.
The U.S. Market is Estimated at $448.3 Million, While China is Forecast to Grow at 7.6% CAGR
The Brachytherapy market in the U.S. is estimated at US$448.3 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$495.3 Million by the year 2030 trailing a CAGR of 7.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.5% and 5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.Select Competitors (Total 24 Featured) -
- Bard Medical Division
- Best Medical International, Inc.
- Best Vascular, Inc.
- Boston Scientific Corporation
- Carl Zeiss Meditec AG
- Elekta AB
- Sirtex Medical Limited
- Sun Nuclear Corporation
- Theragenics Corporation
- Varian Medical Systems, Inc.
- Xoft, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Brachytherapy - A Prelude
- Technological Advances to Boost Brachytherapy Uptake
- Recent Market Activity
- Growing Cancer Cases in Developing Countries Bode Well for the Brachytherapy Market
- Cost Effectiveness - A Major Benefit of Brachytherapy
- Competitive Landscape - An Overview
- Key Market Statistics
- The US Leads the Brachytherapy Devices Market Developing Regions to Spearhead Growth
- Brachytherapy Provides More Hope for Cancer Patients, Compared to EBRT
- Comparison of Brachytherapy Over EBRT in Prostate Cancer Treatment
- Brachytherapy - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
3. MARKET TRENDS & DRIVERS
- Increase in Diagnosed Cases of Cancer - A Major Growth Driver
- Cancer Prone Sites based on Age
- Ballooning Global Population Offers Significant Growth Opportunities
- Rising Healthcare Needs of Aging Global Population Drives Brachytherapy
- Increasing Healthcare Spending in Emerging Markets
- Scientific Evidence Continues to Support Brachytherapy in Prostate Cancer Treatment
- Macular Degeneration - An Emerging Brachytherapy Application
- APBI Therapy Rise in Popularity
- IORT: Attractive Alternative to Traditional Radiation Treatment
- Balloon Brachytherapy Gains Prominence
- Growing Prominence of Imaging Techniques in Brachytherapy
- Radiosensitizers - An Emerging Option to Improve Dose Delivery
- Radiation Safety - An Important Issue in Brachytherapy Treatment
- Residency Training on Brachytherapy - A Way to Improve Clinical Use
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Brachytherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 2: World Historic Review for Brachytherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 3: World 16-Year Perspective for Brachytherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
- Table 4: World Recent Past, Current & Future Analysis for High Dose Rate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 5: World Historic Review for High Dose Rate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 6: World 16-Year Perspective for High Dose Rate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Low Dose Rate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 8: World Historic Review for Low Dose Rate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 9: World 16-Year Perspective for Low Dose Rate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 10: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 11: World Historic Review for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 12: World 16-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 13: World Recent Past, Current & Future Analysis for Gynecological Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 14: World Historic Review for Gynecological Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 15: World 16-Year Perspective for Gynecological Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 16: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 17: World Historic Review for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 18: World 16-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 19: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 20: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 21: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 22: World Brachytherapy Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
UNITED STATES
- Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 23: USA Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 24: USA Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 25: USA 16-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2014, 2023 & 2030
- Table 26: USA Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 27: USA Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 28: USA 16-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2014, 2023 & 2030
CANADA
- Table 29: Canada Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 30: Canada Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 31: Canada 16-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2014, 2023 & 2030
- Table 32: Canada Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 33: Canada Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 34: Canada 16-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2014, 2023 & 2030
JAPAN
- Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 35: Japan Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 36: Japan Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 37: Japan 16-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2014, 2023 & 2030
- Table 38: Japan Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 39: Japan Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 40: Japan 16-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2014, 2023 & 2030
CHINA
- Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 41: China Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 42: China Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 43: China 16-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2014, 2023 & 2030
- Table 44: China Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 45: China Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 46: China 16-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2014, 2023 & 2030
EUROPE
- Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 47: Europe Recent Past, Current & Future Analysis for Brachytherapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 48: Europe Historic Review for Brachytherapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 49: Europe 16-Year Perspective for Brachytherapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
- Table 50: Europe Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 51: Europe Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 52: Europe 16-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2014, 2023 & 2030
- Table 53: Europe Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 54: Europe Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 55: Europe 16-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2014, 2023 & 2030
FRANCE
- Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 56: France Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 57: France Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 58: France 16-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2014, 2023 & 2030
- Table 59: France Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 60: France Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 61: France 16-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2014, 2023 & 2030
GERMANY
- Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 62: Germany Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 63: Germany Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 64: Germany 16-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2014, 2023 & 2030
- Table 65: Germany Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 66: Germany Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 67: Germany 16-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2014, 2023 & 2030
ITALY
- Table 68: Italy Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 69: Italy Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 70: Italy 16-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2014, 2023 & 2030
- Table 71: Italy Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 72: Italy Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 73: Italy 16-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2014, 2023 & 2030
UNITED KINGDOM
- Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 74: UK Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 75: UK Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 76: UK 16-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2014, 2023 & 2030
- Table 77: UK Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 78: UK Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 79: UK 16-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2014, 2023 & 2030
SPAIN
- Table 80: Spain Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 81: Spain Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 82: Spain 16-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2014, 2023 & 2030
- Table 83: Spain Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 84: Spain Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 85: Spain 16-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2014, 2023 & 2030
RUSSIA
- Table 86: Russia Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 87: Russia Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 88: Russia 16-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2014, 2023 & 2030
- Table 89: Russia Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 90: Russia Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 91: Russia 16-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2014, 2023 & 2030
REST OF EUROPE
- Table 92: Rest of Europe Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 93: Rest of Europe Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 94: Rest of Europe 16-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2014, 2023 & 2030
- Table 95: Rest of Europe Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 96: Rest of Europe Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 97: Rest of Europe 16-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2014, 2023 & 2030
ASIA-PACIFIC
- Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Brachytherapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 99: Asia-Pacific Historic Review for Brachytherapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 100: Asia-Pacific 16-Year Perspective for Brachytherapy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
- Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 102: Asia-Pacific Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 103: Asia-Pacific 16-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2014, 2023 & 2030
- Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 105: Asia-Pacific Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 106: Asia-Pacific 16-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2014, 2023 & 2030
AUSTRALIA
- Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
- Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
LATIN AMERICA
- Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
MIDDLE EAST
- Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
AFRICA
- Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bard Medical Division
- Best Medical International, Inc.
- Best Vascular, Inc.
- Boston Scientific Corporation
- Carl Zeiss Meditec AG
- Elekta AB
- Sirtex Medical Limited
- Sun Nuclear Corporation
- Theragenics Corporation
- Varian Medical Systems, Inc.
- Xoft, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 184 |
| Published | April 2024 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 1.6 Billion |
| Forecasted Market Value ( USD | $ 2.3 Billion |
| Compound Annual Growth Rate | 4.6% |
| Regions Covered | Global |
